Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Neurobay is a startup investment consultancy founded in Manchester, England. The organization operates globally, with offices in London, United Kingdom, and Dubai, United Arab Emirates. Neurobay focuses on assisting early-stage companies in raising capital and scaling their operations through innovative strategies and expertise in technology, finance, healthcare, and blockchain.
As of now, Neurobay manages a fund size of $30 million and has supported over 14 companies. The firm has facilitated the raising of approximately £30.25 million for startups, showcasing its commitment to empowering businesses. The team consists of key personnel, including CEO Bilal Khan and several venture partners, who bring a wealth of experience to the organization.
Neurobay has established itself as a significant player in the startup investment landscape, providing a range of services that include capital raising, business advisory, and compliance support. Their notable milestones include a diverse portfolio of companies and a growing presence in the UK and UAE markets.
Neurobay provides a comprehensive range of services aimed at supporting startups and businesses across various sectors, including healthcare, AI, fintech, and consumer markets. Their investment strategy includes capital raising, where they assist companies in connecting with strategic investors to facilitate business growth. The firm also offers tailored business advisory services, helping businesses overcome challenges and maximize opportunities.
In addition to capital raising and advisory services, Neurobay specializes in AML/KYC compliance services, ensuring that businesses meet regulatory standards. They also provide guidance for obtaining crypto licenses in the UAE, navigating the complex regulatory landscape. This multifaceted approach allows Neurobay to cater to the unique needs of startups, making them a valuable partner in the early stages of business development.
Neurobay has supported a diverse range of notable companies, showcasing its commitment to various sectors. The following companies are part of their portfolio:
These companies reflect Neurobay's focus on innovative solutions across various industries, from technology to consumer goods.
Bilal Khan: CEO of Neurobay, Bilal has extensive experience in startup investment and advisory services. He has led numerous initiatives to connect startups with strategic investors and has a strong background in technology and finance.
Abdul Rehman Javed: Venture Partner, Abdul brings expertise in business development and strategic partnerships. He has a proven track record of supporting startups in scaling their operations.
Isaac Walsh: Venture Partner, Isaac specializes in investment analysis and has been instrumental in identifying promising startups for Neurobay's portfolio.
Quasim Zaman: Investment Analyst, Quasim focuses on market research and due diligence, ensuring that Neurobay's investment decisions are well-informed and strategic.
To pitch to Neurobay, founders should use the contact email contact@neurobaystrategy.com and include a comprehensive deck that outlines their business model, market opportunity, and team background. Neurobay prefers detailed information that showcases the startup's potential for growth and innovation.
Response times may vary, but founders should expect to hear back within a few weeks. Warm introductions are beneficial, as they can enhance the chances of receiving a prompt response.
Neurobay runs a program named Neurobay, which focuses on providing capital raising and advisory services to startups. This program is designed to assist early-stage companies in connecting with strategic investors and navigating the complexities of business growth.
Eligibility for the Neurobay program includes startups in sectors such as healthcare, AI, fintech, and consumer markets. Interested companies can apply by reaching out through the contact email provided on their website.
In recent months, Neurobay has highlighted its commitment to supporting startups by showcasing its portfolio of notable companies. They have been active in facilitating introductions to strategic investors and providing tailored business advisory services. The firm continues to expand its presence in the UK and UAE markets, reflecting its dedication to empowering early-stage companies.
Neurobay has also emphasized its expertise in compliance services, particularly in AML/KYC and crypto licensing, positioning itself as a valuable partner for startups navigating regulatory challenges.
What are Neurobay's investment criteria?
Neurobay focuses on early-stage companies in sectors such as healthcare, AI, fintech, and consumer markets. They look for startups that demonstrate innovative solutions and have the potential for significant growth.
How can startups apply or pitch to Neurobay?
Startups can pitch to Neurobay by visiting their website at neurobaystrategy.com and using the contact email contact@neurobaystrategy.com. They should include a detailed business plan and information about their team and market opportunity.
What makes Neurobay different from other investment firms?
Neurobay distinguishes itself by providing not only capital raising services but also tailored business advisory and compliance support, particularly in the areas of AML/KYC and crypto licensing in the UAE.
What is Neurobay's geographic scope?
Neurobay operates globally, with a strong presence in the United Kingdom and the United Arab Emirates. They assist startups in navigating the complexities of raising capital in these regions.
What is the typical check size Neurobay invests?
While specific check sizes are not disclosed, Neurobay's fund size is $30 million, indicating they are positioned to make significant investments in their portfolio companies.
What kind of post-investment involvement does Neurobay have?
Neurobay actively engages with its portfolio companies by providing ongoing business advisory services, facilitating introductions to strategic investors, and ensuring compliance with regulatory standards.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.